Table 4.

Summary of published PLS clinical series

Ref.#	publication	Patients with FU	5y OS	5y DSS	Disease prognosticators
19	Downes et al, 2001	18	45%	50%	NA
3	Gebhard et al, 2002	48	57%	NA	Age, location, size, margins
4	Hornick et al, 2004	50	63%	NA	Location, size, necrosis, mitotic rate, epithelioid subtype
20	Fiore et al, 2007	60	NA	81%1 64%2	Size, status3
5	Dalal et al. 2006	64	NA	59%	Age, gender, status3, Location, margins,
Current	Ghadimi et al. 2010	834	49%	53%5 65%6	Margins, status1

¹DSS of patients with primary disease

²DSS of patients with recurrent disease

³Status refers to tumor status at presentation (primary versus recurrent localized disease)

⁴Including 66 patients with localized disease and 17 with metastatic disease at presentation

⁵DSS of all evaluable patients

⁶DSS of patients with localized disease